The therapeutic effect of DL-3-n- butylphthalide in rats with chronic cerebral hypoperfusion through downregulation of amyloid precursor protein and matrix metalloproteinase-2

Journal of International Medical Research

Volumn 40, Issue 3, 2012, Pages 967-975

  Wei, Weiwei ^a,b   Zhang, W ^a   Huang, Y ^a   Li, Y ^a   Zhu, G ^a   Chen, F ^a   Li, J ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Amyloid precursor protein; B Amyloid 40; Cerebral hypoperfusion; DL 3 n Butylphthalide; Immunohistochemistry; Matrix metalloproteinase; Western blot

Indexed keywords

3 BUTYLPHTHALIDE; AMYLOID BETA PROTEIN[1-40]; GELATINASE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN DISEASE; BRAIN PERFUSION; BRAIN REGION; CEREBRAL HYPOPERFUSION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; ENDOTHELIUM CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING; MALE; MAZE TEST; MEMORY CONSOLIDATION; NONHUMAN; PROTEIN FUNCTION; RAT; TASK PERFORMANCE; TREATMENT RESPONSE; WESTERN BLOTTING;

EID: 84863111952     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000315     Document Type: Article

References (21)

1. Chao CP, Kotsenas AL, Broderick DF: Cerebral amyloid angiopathy: CT and MR imaging findings. Radiographics 2006; 26: 1517-1531.
2. Vinters HV: Cerebral amyloid angiopathy. A critical review. Stroke 1987; 18: 311-324.
3. Okazaki H, Reagan TJ, Campbell RJ: Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979; 54: 22-31.
4. de Figueiredo RJ, Oten R, Su J, et al: Amyloid deposition in cerebrovascular angiopathy. Ann NY Acad Sci 1997; 826: 463-471.
5. Huse JT, Pijak DS, Leslie GJ, et al: Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme. J Biol Chem 2000; 275: 33729-33737.
6. Van Lint P, Libert C: Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007; 82: 1375-1381.
7. Romanic AM, Madri JA: Extracellular matrixdegrading proteinases in the nervous system. Brain Pathol 1994; 4: 145-156.
8. Hamann GF, Okada Y, Fitridge R, et al: Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995; 26: 2120-2126.
9. Hernandez-Guillamon M, Mawhirt S, Fossati S, et al: Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-β E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells. J Biol Chem 2010; 285: 27144-27158.
10. Wang Y, Huang LQ, Tang XC, et al: Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia. Acta Pharmacol Sin 2010; 31: 649-664.
11. Chang Q, Wang XL: Effects of chiral 3-nbutylphthalide on apoptosis induced by transient focal cerebral ischemia in rats. Acta Pharmacol Sin 2003; 34: 796-804.
12. Liu XG, Feng YP: Protective effect of DL-3-nbutylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia. Yao Xue Xue Bao 1995; 30: 896-903 [in Chinese, English abstract].
13. Peng Y, Sun J, Hon S, et al: L-3-n-Butylphthalide improves cognitive impairment and reduces amyloid-β in a transgenic model of Alzheimer's disease. J Neurosci 2010; 30: 8180-8189.
14. Feng YP, Hu D, Zhang LY: Effect of DLbutylphthalide (NBP) on mouse brain energy metabolism in complete brain ischemia induced by decapitation. Yao Xue Xue Bao 1995; 30: 741-744 [in Chinese, English abstract].
15. Morris R: Developments of water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47-60.
16. Zipfel GJ, Han H, Ford AL, et al: Cerebral amyloid antiopathy: progressive disruption of the neurovascular unit. Stroke 2009; 40(3 suppl): S16-S19.
17. Davis J, Wagner MR, Zhang W, et al: Amyloid β-protein stimulates the expression of urokinasetype plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells. J Biol Chem 2003; 278: 19054-19061.
18. Jung SS, Zhang W, Van Nostrand WE: Pathogenic Aβ induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells. J Neurochem 2003; 85: 1208-1215.
19. Ihara M, Tomimoto H, Kinoshita M, et al: Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J Cereb Blood Flow Metab 2001; 21: 828-834.
20. Li J, Li Y, Ogle M, Zhou X, et al: DL-3-n-Butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway. Brain Res 2010; 1359: 216-226.
21. Feng X, Peng Y, Liu M, et al: DL-3-n-Butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis. Neuropharmacology 2012; 62: 1004-1010.